The Lesion of the Rat Substantia Nigra pars compacta Dopaminergic Neurons as a Model for Parkinson's Disease Memory Disabilities

被引:0
作者
Claudio Da Cunha
Miriam Elizabeth Mendes Angelucci
Newton S. Canteras
Susan Wonnacott
Reinaldo N. Takahashi
机构
[1] Laboratório de Fisiologia e Farmacologia do SNC,Departamento de Farmacologia, UFPR
[2] University of Bath,Department of Biology and Biochemistry
[3] UFSC,Departamento de Farmacologia
来源
Cellular and Molecular Neurobiology | 2002年 / 22卷
关键词
Parkinson's disease; MPTP; substantia nigra pars compacta; memory; striatum; dopamine; caffeine;
D O I
暂无
中图分类号
学科分类号
摘要
1. In this article we review the studies of memory disabilities in a rat model o Parkinson's disease (PD).
引用
收藏
页码:227 / 237
页数:10
相关论文
共 185 条
[1]  
Angelucci M. E.(1999)The effect of caffeine in animal models of learning and memory Eur. J. Pharmacol 373 135-140
[2]  
Vital M. A.(1992)Behavioural analysis of unilateral monoamine depletion in the marmoset Brain 115 825-856
[3]  
Cesario C.(1971)Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment Arch. Neurol. 25 145-150
[4]  
Zadusky C. R.(1997)Sensory and cognitive functions of the basal ganglia Curr. Opin. Neurobiol. 7 157-163
[5]  
Rosalen P. L.(2000)Electrophysiology of dopamine in normal and denervated striatal neurons Trends Neurosci. 23 S57-S63
[6]  
Da Cunha C.(1977)Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei Brain Res. 123 89-111
[7]  
Annett L. E.(1996)Caffeine and cocaine interaction on memory consolidation in mice Arch. Int. Pharmacodyn. Ther. 331 94-104
[8]  
Rogers D.C.(2001)Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease J. Neurosci. 21 RC143-18
[9]  
Hernandez T.D.(2001)Memory disruption in rats with nigral lesions induced by MPTP: A model for early Parkinson's disease amnesia Behav. Brain Res. 124 9-8
[10]  
Dunnett S.B.(1997)Cognitive deficits in Parkinson's disease J. Neurol. 244 2-111